Find
Home
Clinical Trials
Symptom Management
Videos
OncUTube Home
Continuing Education
Calendar
Links
You are here:
Videos
Register
|
Login
Install latest flash player if this video gallery doesn't work.
SHARE THIS VIDEO
ENETS 2011 (3 of 7): Can Biomarkers Be Used to Predict Response to Everolimus in Patients with Pancreatic NETs?
Dr. Kjell Oberg reviews the role of biomarkers in patient with pNETS as part of a continuing series, Headline News in NETS 2011.
This program is supported by an un-restricted educational grant from Novartis Oncology and intended for non-US audiences only.
Role of Chromogranin A and Neuron-Specific Enolase Biomarkers in PFS with Everolimus versus Placebo in Patients with Advanced NETS - Radiant 3 Results Poster
ENETS: European Neuroendocrine Tumor Society Website
Recent Video
|
Most Viewed
Tumor Type :
<All Tumor Types>
Advocacy Group Interviews
Brain Cancer
Breast Cancer
Clinical Trial Cooperative Groups
Colorectal Cancer
Gastric Cancer
Gastrointestinal Stromal Tumor (GIST) Cancer
General Educational Topics
Head and Neck Cancer
Headline News
Leukemia
Lung Cancer
Lymphoma
Melanoma
Myeloma
Myeloproliferative Neoplasms (MPN)
Neuroendocrine Tumors (NET)
Oncology Nursing Society
Ovarian Cancer
Pancreatic Cancer
Pediatric Oncology
Prostate Cancer
Renal Cell Carcinoma (Kidney) Cancer
Sarcomas
Supportive Care
Symptom Management
Technology and Medicine
Thyroid Cancer
Search :
Decision to Treat Advanced Malignancies — in...
05:02
Acute Myeloid Leukemia (AML) — interview wit...
02:45
Bosutinib Versus Imatinib (CML) Follow-up St...
05:22
Update on JAK Inhibitor — COMFORT II Trial i...
06:50
Update on JAK Inhibitor — Spleen Volume Redu...
10:20
Asparaginase as a Treatment in Acute Lymphob...
07:19
NTDT, or Non–transfusion-dependent Thalassem...
06:33
Brentuximab Vedotin in T-Cell Lymphoma — int...
05:21
Multiple Myeloma — interview with David H. V...
05:10
Personalized Medicine, Genomics and Biomarke...
05:33
Leucovorin Rescue in Managing Recurrent Pral...
08:00
Chronic Myeloid Leukemia (CML) Update — inte...
04:21
High Expression of CRBN That Is Associated W...
03:29
Robert Rosen, Chairman of the MPN Research F...
04:06
Ravindra Sarode, MD, and President-Elect of ...
03:24
Nilotinib Versus Imatinib in Patients With N...
04:46
Effect of Everolimus on Markers of Angiogene...
07:47
Updated Survival and Safety Data From RADIAN...
07:32
Everolimus + Octreotide LAR in Patients With...
08:00
Colon and Rectal Cancer: A Racial Divide
23:21
Overview of the COMFORT II trial and discuss...
07:58
COMFORT II Discussion with Dr. Claire Harris...
05:45
COMFORT II - Why is spleen volume so importa...
05:29
COMFORT II Additional Data Discussion with D...
01:35
What do the results of the COMFORT I and II ...
02:43
TIVO-1, Phase 3 Study in Advanced Kidney Can...
05:45
Evaluation of BCR-ABL monitoring in Chronic ...
04:04
An interview Andrew Spiegel, CEO and Co-Foun...
03:01
Correlation of Treatment-emergent Adverse Ev...
03:24
Colon Cancer and Patient Compliance
02:49
What is Familial Adenomatous Polyposis or FA...
04:00
My Cancer Advisor
01:25
The Patient Resource Cancer Guide
03:13
Kidney Cancer Association – We’re Here to He...
06:13
Disparities in Colon Cancer Rates Afflictin...
05:20
Integrative Medicine: Vitamin C’s Positive E...
09:24
Genetics and Cancer, a Current Neo-Adjuvant ...
04:27
Overview of the Melanoma Research Foundation...
04:33
Stage III-IV Head and Neck Squamous Cell Car...
09:15
Healthy and Fit After Cancer – Optimal heal...
04:34
YES ! – Beat Liver Tumors
01:23
Volontie 1 Foundation - Rehabilitating Cance...
03:03
Benefit of Denosumab Therapy in Patients Wit...
04:27
A Phase II Study of Low-dose Protracted Irin...
04:15
Updated Overall Survival and PFS by Blinded ...
05:08
Progression-Free Survival from a Phase 1 Stu...
03:20
Acral Lentiginous Melanoma in Hawaii: Charac...
02:24
Phase II Trial of Neoadjuvant/Adjuvant Imati...
03:06
24 Months Follow-Up From the Patient’s Anast...
03:25
Surviving Childhood Cancer – What Next? Cha...
04:36
The Turkish Pediatric Oncology Society
06:40
Second Malignant Tumors in Childhood Cancer ...
06:33
Denosumab vs. Zoledronic Acid in Patients wi...
05:57
Identification of Pre- and Post-Treatment Ma...
03:48
Advances in Immunotherapy and Melanoma
02:38
The Cholangiocarcinoma Foundation
05:03
Study Finds Vaccine Extends Recurrent GBM Su...
04:14
Phase II study of the Hsp90 inhibitor ganete...
08:13
Ganetespib (STA-9090) as Monotherapy in Pati...
03:39
Overview of the Cutaneous Lymphoma Foundatio...
04:39
Does Zoledronic Acid Reduce Skeletal-Related...
03:32
Are There Benefits to Long-Term Bisphosphona...
06:33
Phase 3 Axitinib Data in patients with previ...
09:51
JAK Inhibitor Ruxolitinib COMFORT-II Trial S...
06:19
Phase 3 AXIS 1032 Trial Discussion with Bria...
03:17
An Overview of Myelofibrosis
04:42
What Do Patients with Myelofibrosis Need to ...
04:21
JAK/STAT Pathway: Discussion on Current Stud...
00:36
JAK/STAT Pathway: Overview
02:32
Management Considerations for Patients with ...
01:49
Myeloproliferative Neoplasms: Clinical Prese...
03:08
Myeloproliferative Neoplasms: WHO Classifica...
01:33
What Are Myeloproliferative Neoplasms (MPNs)...
02:53
The Importance of Quality End of Life Care f...
06:58
Susan Moore - ManageCRC.com and Colorectal C...
06:08
Pam Viale - ManageCRC.com and Colorectal Can...
06:28
Carolyn Grande - ManageCRC.com and Colorecta...
05:43
Unmet Information Needs and Quality of Life ...
03:57
Robert Martinez: Cure Magazine's 2011 Extrao...
04:22
Rebecca Wojtecki: Cure Magazine's 2011 Extra...
06:49
Marie Hayak: Cure Magazine's 2011 Extraordin...
04:31
Charlie Lustman: Keynote Speaker at ONS 2011...
03:47
Charlie Lustman: Keynote Speaker at ONS 2011
07:29
Nurses' knowledge, attitude, and practice re...
04:16
Summary of Cardiac Effects of NILOTINIB and ...
03:54
What oncology nurses may not know about canc...
04:04
Assessment of genetic predisposition to seco...
06:38
Neuroendocrine Tumors - Education, Awareness...
05:18
Durable Responses with NILOTINIB in Patients...
04:22
The Importance of Awareness About Ovarian Ca...
06:10
Chinese American Breast Cancer Survivors' Ex...
10:17
Perceived Providers' Support and Lymphedema ...
07:05
Chemotherapy-Related Cognitive Impairment: T...
06:13
An Interview With George W. Sledge, Outgoing...
09:49
NSABP Protocol P-5, The Statin Polyp Prevent...
06:56
The Impact of the NSABP on Patient Care and ...
04:33
Featuring Two Clinical Trials for Breast Can...
15:12
ENETS 2011(1 of 7): Implications of Crossove...
05:40
ENETS 2011 (2 of 7): Survival Analyses in pN...
06:33
ENETS 2011 (3 of 7): Can Biomarkers Be Used ...
06:39
RSS this page
Advertise on OncUView.tv
Privacy Statement
|
Terms Of Use
|
Copyright 2010-2011 by OncUView.tv, LLC